Transcripts Ribomic Inc.

Equities

4591

JP3974850004

Delayed Japan Exchange Other stock markets 22:23:11 2024-05-22 EDT			5-day change	1st Jan Change
83 ^JPY	0.00%		-1.19%	-23.15%

03-07	Ribomic Inc. announced that it has received ¥4.192212 million in funding from SMBC Nikko Securities Inc.	CI
02-20	Ribomic Inc. announced that it expects to receive ¥4.192212 million in funding from SMBC Nikko Securities Inc.	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023	22-11-11	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023	22-08-09	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Full Year Ending March 31, 2022	22-05-13	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2022	21-11-09	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	21-08-06	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2022	21-05-25	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2021	21-02-11	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Full Year Ending March 31, 2021	20-08-06	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Full Year Ending March 31, 2021	20-05-13	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2020	20-02-06	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020	19-11-27	CI
Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2020	19-08-23	CI
Ribomic Inc. Announces Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2018	17-08-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer